Home › Malattie polmonari › South Carolina
Studi clinici su Malattie polmonari nello stato di South Carolina
11 studi su Malattie polmonari cercano partecipanti presso sedi nello stato di South Carolina.
Città nello stato di South Carolina
Testo ufficiale dello studio (inglese)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Greenville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Medical University of South Carolina Ashley River Tower, Charleston
- Medical University of South Carolina - SCTR Research Nexus, Charleston
- Medical University of South Carolina, Charleston
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Medical University of South Carolina Infectious Disease Clinic, Charleston
- Medical University of South Carolina Investigational Drug Services (IDS), Charleston
- Medical University of South Carolina Investigational Drug Services Pharmacy, Charleston
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07013474American Lung Association (ALA) Lung Health Cohort
- Medical University of South Carolina, Charleston
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 25 a 35 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research of Rock Hill, Rock Hill
In reclutamentoFase 2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Medical University of South Carolina, Charleston
- Prisma Health Cancer Institute, Greenville
- Lexington Medical Center, West Columbia
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Research of Rock Hill, Rock Hill
In reclutamentoFase 3
Età 40 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Charleston
In reclutamentoFase 2
Età da 18 a 85 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07333183A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
In reclutamentoFase 3
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT07555483Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Bogan Sleep Consultants, LLC, Columbia
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 12 nov 2025 · NCT05975983Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Medical University of South Carolina, Charleston
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2025 · NCT04555161Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.